Absci (ABSI) Assets (2020 - 2026)
Absci (ABSI) posted Assets of $195.6 million for Q1 2026, down 9.57% sequentially from $216.3 million in Q4 2025, and down 15.85% YoY from $232.4 million in Q1 2025.
Absci (ABSI) Assets (2020 - 2026) Analysis & Trends
Absci has reported Assets for 7 years, with the latest figure at $195.6 million in Q1 2026.
- Quarterly Assets fell 15.85% year-over-year to $195.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195.6 million (down 15.85% YoY) and the FY2025 annual result came in at $216.3 million, up 1.26% from the prior year.
- Assets eased to $195.6 million in Q1 2026 per ABSI's latest filing, from $216.3 million in the prior quarter.
- Over five years, Assets peaked at $395.5 million in Q1 2022 and troughed at $195.6 million in Q1 2026.
- A 5-year average of $265.0 million and a median of $245.0 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets surged 42.5% in 2022, then sank 32.31% in 2023.
- Over 5 years, Assets stood at $321.0 million in 2022, then plunged by 32.31% to $217.3 million in 2023, then declined by 1.7% to $213.6 million in 2024, then advanced by 1.26% to $216.3 million in 2025, then fell by 9.57% to $195.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $195.6 million, $216.3 million, and $245.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 268.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 268.92 Mn |
| Mar 31, 2026 | 195.59 Mn |
| Dec 31, 2025 | 216.30 Mn |
| Sep 30, 2025 | 244.99 Mn |
| Jun 30, 2025 | 209.89 Mn |
| Mar 31, 2025 | 232.45 Mn |
| Dec 31, 2024 | 213.61 Mn |
| Sep 30, 2024 | 235.23 Mn |
| Jun 30, 2024 | 255.53 Mn |
| Mar 31, 2024 | 274.90 Mn |
| Dec 31, 2023 | 217.30 Mn |
| Sep 30, 2023 | 236.34 Mn |
| Jun 30, 2023 | 254.15 Mn |
| Mar 31, 2023 | 295.81 Mn |
| Dec 31, 2022 | 321.01 Mn |
| Sep 30, 2022 | 339.39 Mn |
| Jun 30, 2022 | 366.32 Mn |
| Mar 31, 2022 | 395.46 Mn |
| Dec 31, 2021 | 426.20 Mn |
| Sep 30, 2021 | 449.12 Mn |